| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

( McArdle Memorial Laboratory, Medical School, University of Wisconsin, Madison 6, Wis.)
The irreversible chemical binding of 1,2,5,6-dibenzanthracene-9,10-C14 to the proteins of a skin fraction containing epidermis and part of the dermis has been demonstrated. The variation of specific activity of the protein with time after application has been determined. The binding occurs only in vivo and is not due to surface adsorption. The binding occurs between the carcinogen or its metabolite and the nucleoproteins, particulate and soluble proteins, but not with nucleic acids. The possible significance of this phenomenon in the carcinogenic process is discussed.
* An abstract of this report appeared in Cancer Research, 12:308, 1952.
This work was supported by a grant from the Wisconsin Section of the American Cancer Society, by a grant-in-aid from the National Cancer Institute, and by the Pearl and W. M. Quandt Memorial Fund.
Present address: Department of Biochemistry, University of Utah Medical School, Salt Lake City, Utah.
This article has been cited by other articles:
![]() |
A. M. Brues Critique of the Linear Theory of Carcinogenesis: Present data on human leukemogenesis by radiation indicate that a nonlinear relation is more probable Science, September 26, 1958; 128(3326): 693 - 699. [Abstract] [PDF] |
||||
![]() |
H. I. HADLER, V. DARCHUN, and K. LEE Route of Elimination of Anthracene and 9-Methylanthracene Involving Protein Binding Science, January 11, 1957; 125(3237): 72 - 73. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |